Open Email...Your Power Lunch Trades Ideads Inside…
| | | | | | | Dear Reader, | | I hope you are having a great Friday and also hope you have a good weekend ahead of you! I am sending you the list of options signals for the next trading day (to help you cut your research in finding trading and/or investing opportunities). | NNVC: This Tiny Biotech Could Break Out in 2026 (ad)*
NanoViricides (NYSE: NNVC) is approaching a pivotal moment as its lead antiviral, NV-387, advances toward Phase II. Unlike traditional antivirals, NV-387 uses a nanoviricide platform designed to directly attack viruses while shielding organs from immune-related damage. It has shown remarkable survival benefits in humanized animal models and demonstrated strong safety in Phase I trials. With measles outbreaks rising and global viral threats expanding, NV-387's broad-spectrum potential—from influenza and RSV to MPox and smallpox—positions NNVC for major commercial traction. Two Phase II tracks, including an MPox trial in Congo and a multi-virus trial in India, set up a significant 2026 catalyst.
👉 Discover why NV-387 could become one of 2026's most important antiviral breakthroughs. | | Stock Name | Signal Date | Signal Name |
|---|
| LLY | Nov 14 | Golden Crossover | | ABT | Nov 14 | Golden Crossover | | MCD | Nov 14 | Golden Crossover | | LIN | Nov 14 | Golden Crossover | | MA | Nov 14 | Below 200-MA | | BKNG | Nov 14 | Below 200-MA | | SPOT | Nov 14 | Below 200-MA | | HON | Nov 14 | Below 200-MA | | MSFT | Nov 14 | Double Top | | TSA | Nov 14 | Double Top | | EBAY | Nov 14 | Double Top | | NRG | Nov 14 | Double Top | | NVO | Nov 14 | Double Bottom | | KVUE | Nov 14 | Double Bottom | | CTRA | Nov 14 | Double Bottom | | DOW | Nov 14 | Double Bottom | | Click Here to View Your Full Report |
| | | | | Why Top Traders Are Leaning on A.I. in Today's Market (ad)
Markets are more chaotic, politicized, and algorithm-driven than ever — and that's why elite traders rely on VantagePoint A.I. Its proprietary neural networks forecast trends days before they happen, with 87.4% verified accuracy across stocks, commodities, ETFs, and currencies. It correctly flagged gold's 50% launch past $4,000, while most analysts were still doubting the move. Now VantagePoint is hosting a free live training to reveal the next forecasted turning points — and the signals driving them.
🚀 Secure your seat now and see tomorrow's trends before the market reacts. | | How to use signals in your trading/investing strategies: | | Options Trading - if you are an Options trader, you can use the Ride-the-Wave strategy (to target multi-day price momentum following a company's trade signal) or the Price Reversal strategy (to target the reversal following signal generation). Please click on Ride-the-Wave Strategy to learn more about it. | | Stock Trading - If you're a swing stock trader/investor or portfolio manager, you may want to consider entering or exiting your positiosn based on a the signal generation. Please click on Volatility Crush Strategy to learn more about it. | NNVC: The Under-the-Radar Biotech That Could Redefine Antiviral Therapy in 2026 (ad)*
NanoViricides (NYSE: NNVC) is advancing NV-387, a broad-spectrum antiviral that neutralizes viruses before they infect cells while protecting the lungs from immune-driven damage. With U.S. measles cases rising, NV-387 has shown 130% increased survival and strong lung protection in humanized models. Phase I trials confirmed safety, and its oral gummy formulation makes it patient-friendly during severe illness. NV-387's nanoviricide "Re-Infection Inhibition" technology targets measles, RSV, influenza, COVID-19, MPox, H5N1, and even smallpox—unlocking multi-billion-dollar global markets. Two Phase II tracks—a Congo MPox study and a multi-virus basket trial in India—position NNVC for major catalysts in 2026.
👉 Learn why NV-387 could be one of 2026's biggest antiviral breakthroughs. | | At Options Hero, we're really excited to help you trade more confidently. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader. | | To your trading success, | | Support Team | | Options Hero | | PS:Options Hero is morning newsletter, powered by StockEarnings proprietary technology. | | | | | | |
| | | (ad)* This message is a PAID ADVERTISEMENT for NanoViricides, Inc (NYSE: NNVC) from Interactive Offers. StockEarnings, Inc. has received a fixed fee of $7000.00 from Interactive Offers for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between Nov 14, 2025 and Nov 20, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either NanoViricides, Inc (NYSE: NNVC) or Interactive Offers. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding NanoViricides, Inc (NYSE: NNVC) on Smallcaps Daily website for additional information about the relationship between Interactive Offers and NanoViricides, Inc (NYSE: NNVC). Options Hero is a subsidiary of StockEarnings, Inc (SE). SE is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities. This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised. All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please click here for SE Disclaimers. StockEarnings Inc 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA | W: 877.6.STOCKS | Unsubscribe
Today's Bonus Content: My plan to make $8k by Monday morning?
| | |
